SeaStar Medical Holding Corp (ICU)
4.28
+0.22
(+5.42%)
USD |
NASDAQ |
Sep 27, 16:00
4.24
-0.04
(-0.93%)
After-Hours: 20:00
SeaStar Medical SG&A Expense (TTM): 8.285M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 8.285M |
March 31, 2024 | 7.719M |
December 31, 2023 | 8.317M |
September 30, 2023 | 11.15M |
June 30, 2023 | 10.36M |
Date | Value |
---|---|
March 31, 2023 | 9.31M |
December 31, 2022 | 6.916M |
September 30, 2022 | 2.867M |
June 30, 2022 | 2.141M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
2.141M
Minimum
Jun 2022
11.15M
Maximum
Sep 2023
7.452M
Average
8.285M
Median
Jun 2024
SG&A Expense (TTM) Benchmarks
Bolt Biotherapeutics Inc | 22.00M |
CVS Health Corp | -- |
Walgreens Boots Alliance Inc | 28.16B |
Nuwellis Inc | 14.88M |
Verastem Inc | 36.57M |